Cargando…
Cidofovir Activity against Poxvirus Infections
Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside analog approved since 1996 for clinical use in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. Cidofovir (CDV) has broad-spectrum activity against DNA viruses, including herpes-, adeno-...
Autores principales: | Andrei, Graciela, Snoeck, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185586/ https://www.ncbi.nlm.nih.gov/pubmed/21994641 http://dx.doi.org/10.3390/v2122803 |
Ejemplares similares
-
Cidofovir in the treatment of poxvirus infections
por: De Clercq, Erik
Publicado: (2002) -
Cidofovir in the therapy and short-term prophylaxis of poxvirus infections
por: De Clercq, Erik
Publicado: (2002) -
New prodrugs of Adefovir and Cidofovir
por: Tichý, Tomáš, et al.
Publicado: (2011) -
Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage
por: De Schutter, Tim, et al.
Publicado: (2013) -
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms
por: Mertens, Barbara, et al.
Publicado: (2016)